Novo Nordisk’s Wegovy Becomes First GLP-1 Oral Pill After FDA Approval

Novo Nordisk’s Wegovy Becomes First GLP-1 Oral Pill After FDA Approval The Wegovy pill has also been approved for reducing cardiovascular risks. Novo plans to launch the drug in January. Also in the news: the U.S. strikes health funding deals with nine African countries; Trump wants fewer guardrails on AI in health; and more. https://kffhealthnews.org/morning-breakout/novo-nordisks-wegovy-becomes-first-glp-1-oral-pill-after-fda-approval/